Skip to main content

Advertisement

SpringerLink
Log in

Design, Synthesis and Cytotoxicity Evaluation of N-(5-Benzylthio)-4H-1,2,4-Triazol-3-YL)-4-Fluorobenzamide Derivatives as Potential Anticancer Agents

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

Despite advances in anticancer drug development and discovery, the survival of patients is so poor. A deep need for discovery of novel anticancer drugs is among priority issues in medicinal chemistry now. A new series of 1,2,4-triazole derivatives were designed and synthesized by means of bioisosteric replacement. In vitro cytotoxicity evaluation was carried out with respect to PC3 (prostate carcinoma), HT29 (colorectal cancer) and SKNMC (neuroblastoma) cell lines using MTT assay, and the obtained results were compared to imatinib as a reference drug. Spectroscopic methods including 1H NMR, IR, and MS were used for characterization of the synthesized compounds. Generally, none of the tested compounds showed superior activity in comparison to imatinib against PC3 and SKNMC cell lines. However, compound 3b (IC50 = 3.69 ± 0.9 μM) and 3e(IC50 = 15.31 ± 2.1 μM) exhibited higher activity than imatinib (18.1 ± 2.6) against HT29 cells. Some of the obtained 1,2,4-triazole derivatives can be proposed as potential anticancer agents – in particular, against colorectal cancer – but further structural modifications and experimental tests are needed to increase the anticancer activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Scheme 1

Similar content being viewed by others

References

  1. H. A. Bhuran and S. J. Kini, J. Mol. Graph. Model., 29, 32 – 37 (2010).

    Article  CAS  Google Scholar 

  2. S. Madhusudan, S. Trivadi and T. S. Ganesan, Clin. Biochem., 37, 618 – 635 (2004).

    Article  PubMed  CAS  Google Scholar 

  3. M. Radi, E. Crespan, G. Botta, et al., Bioorg. Med. Chem. Lett., 18, 1207 – 1211 (2008).

    Article  PubMed  CAS  Google Scholar 

  4. S. Nussbaumer, P. Bonnabry, J. Veuthey and S. Fleury-Souverain, Talanta, 85, 2265 – 2289 (2011).

    Article  PubMed  CAS  Google Scholar 

  5. A. Arora and E. M. Scholar, J. Pharmacol. Exp. Ther., 3, 971 – 979 (2005).

    Article  CAS  Google Scholar 

  6. T. Albreht, M. Mckee, D. M. Alexe, et al., Eur. J. Cancer, 44, 145114 – 56 (2008).

    Article  Google Scholar 

  7. J. Ferlay, P. Autier, M. Boniol, et al., Ann. Oncol. 18, 581 – 592 (2007).

    Article  PubMed  CAS  Google Scholar 

  8. A. Jemal, R. Siegel, E. Ward, et al., Cancer J. Clin. 56, 106 – 130 (2006).

    Article  Google Scholar 

  9. N. Demýrbaþ and R. Ugurluoglu, Turk. J. Chem., 28, 679 – 690 (2004).

    Google Scholar 

  10. H. Yüksek, Z. Ocak, M. Alkan, et al., Molecules, 9, 232 – 240 (2004).

    Article  PubMed  Google Scholar 

  11. O. Gurso Kol and H. Yuksek, Eur. J Chem., 1, 123 – 136 (2010).

    Google Scholar 

  12. K. Sztanke, T. Tuzimski, J. Rzymowska, et al., Eur. J. Med. Chem., 43, 404 – 419 (2008).

    Article  PubMed  CAS  Google Scholar 

  13. B. Shivarama Holla, B. Kunhanna Sarojini, B. Sooryanarayana Rao, et al., Il Farmaco, 56, 565 – 570 (2001).

    Article  Google Scholar 

  14. Y. A. Al-Soud, M. N. Al-Dweri and N. A. Al-Masoudi, Il Farmaco, 59, 775 – 783 (2004).

    Article  PubMed  CAS  Google Scholar 

  15. X. Ouyang, X. Chen, E. L. Piatnitski, et al., Bioorg. Med. Chem. Lett., 15, 5154 – 5159 (2005).

    Article  PubMed  CAS  Google Scholar 

  16. A. K. Saha, L. Liu, R. Simoneaux, et al., Bioorg. Med. Chem. Lett., 15, 5407 – 5411 (2005).

    Article  PubMed  CAS  Google Scholar 

  17. Y. Shi and C. H. Zhou, Bioorg. Med. Chem. Lett., 21, 956 – 960 (2011).

    Article  PubMed  CAS  Google Scholar 

  18. P. L. Zhao, A. N. Duan, M. Zou, et al., Bioorg. Med. Chem. Lett., 22, 4471 – 4474 (2012).

    Article  PubMed  CAS  Google Scholar 

  19. N. S. A. M. Khalil. Eur. J. Med. Chem., 45, 5265 – 5277 (2010).

    Article  PubMed  CAS  Google Scholar 

  20. M. Balba, N. Abd El-Hady, N. Taha, et al., Eur. J. Med. Chem. 46, 2596 – 2601 (2011).

    Article  PubMed  CAS  Google Scholar 

  21. S. Eswaran, A. V. Adhikari and N. S. Shetty, Eur. J. Med. Chem., 44, 4637 – 4647 (2009).

    Article  PubMed  CAS  Google Scholar 

  22. L. Guo, Z. S. Li, H. L. Wang, et al., Eur. J. Pharmacol., 538, 15 – 22 (2006).

    Article  PubMed  CAS  Google Scholar 

  23. B. Shivarama Holla, K. Narayana Poojary, B. Sooryanarayana Rao, and M. K. Shivananda, Eur. J. Med. Chem., 37, 511 – 517 (2002).

    Article  PubMed  CAS  Google Scholar 

  24. B. Shivarama Holla, B. Veerendra, M. K. Shivananda and B. Poojary, Eur. J. Med. Chem., 38, 759 – 767 (2003).

    Article  PubMed  CAS  Google Scholar 

  25. Y. Özkay, Ý. Iþýkdag, Z. Ýncesu and G. Akalýn, Eur. J. Med. Chem., 45, 3320 – 3328 (2010).

    Article  PubMed  CAS  Google Scholar 

  26. P. Singh, R. Raj, V. Kumar, M. P. Mahajan, et al. Eur. J. Med. Chem., 47, 594 – 600 (2012).

    Article  PubMed  CAS  Google Scholar 

  27. A. Mohammadi-Farani, A. Foroumadi, M. Rezvani Kashani and A. Aliabadi, Iran J. Basic Med. Sci., 17, 502 – 508 (2014).

    PubMed Central  PubMed  Google Scholar 

  28. A. Aliabadi, E. Eghbalian and A. Kiani, Iran J. Basic Med. Sci., 11, 1133 – 1138 (2013).

    Google Scholar 

Download references

Acknowledgements

The current project was supported by the research council of Kermanshah University of Medical Sciences financially. This work was performed in partial fulfillment of the requirement for PharmD of Mrs. Maryam Azizi.

Author information

Authors and Affiliations

  1. Novel Drug Delivery Research Center, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran

    Alireza Aliabadi, Ahmad Mohammadi-Frarni, Maryam Azizi & Farahnaz Ahmadi

  2. Department of Medicinal Chemistry, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran

    Alireza Aliabadi

  3. Department of Pharmacology, Toxicology and Medical Services, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran

    Ahmad Mohammadi-Frarni & Farahnaz Ahmadi

  4. Students Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran

    Maryam Azizi

Authors
  1. Alireza Aliabadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ahmad Mohammadi-Frarni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maryam Azizi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Farahnaz Ahmadi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alireza Aliabadi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aliabadi, A., Mohammadi-Frarni, A., Azizi, M. et al. Design, Synthesis and Cytotoxicity Evaluation of N-(5-Benzylthio)-4H-1,2,4-Triazol-3-YL)-4-Fluorobenzamide Derivatives as Potential Anticancer Agents. Pharm Chem J 49, 694–699 (2016). https://doi.org/10.1007/s11094-016-1355-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-016-1355-8

Keywords

Search

Navigation